Peter Schoene1, Jason Coult2, Lauren Murphy1, Carol Fahrenbruch3, Jennifer Blackwood3, Peter Kudenchuk4, Lawrence Sherman2, Thomas Rea5. 1. Department of Medicine University of Washington School of Medicine, Seattle, Washington. 2. Department of Bioengineering, Seattle, Washington. 3. King County Emergency Medical Services Division, Seattle, Washington. 4. Department of Medicine University of Washington School of Medicine, Seattle, Washington; King County Emergency Medical Services Division, Seattle, Washington. 5. Department of Medicine University of Washington School of Medicine, Seattle, Washington; King County Emergency Medical Services Division, Seattle, Washington. Electronic address: rea123@u.washington.edu.
Abstract
BACKGROUND: Quantitative measures of the ventricular fibrillation waveform at the outset of resuscitation are associated with survival. However, little is known about the course of these measures during resuscitation and how this course is related to outcome. OBJECTIVE: The purpose of this study was to determine how waveform measures change over the course of resuscitation and whether these changes might be used to guide resuscitation. METHODS: We evaluated 390 persons treated by emergency providers following out-of-hospital ventricular fibrillation arrest. We assessed the ventricular fibrillation waveform using the amplitude spectrum area (AMSA) from the defibrillator's continuous electrocardiogram measured before each of the first three shocks. We used logistic regression to evaluate the relationship of AMSA and the change in AMSA with favorable neurologic survival as determined by the Cerebral Performance Category at hospital discharge 1-2. RESULTS: Of the 390 patients who received an initial shock, 273 required a second shock and 210 required a third shock. The mean (standard deviation) for AMSA was 9.64 (0.52) for the 873 total shock cycles. AMSA₁ measured before the first shock was strongly associated with favorable neurologic survival (odds ratio [OR] 3.40, 95% confidence interval [CI] [2.48, 4.66] for 1 SD change). We observed a similar relationship for second-shock AMSA₂ (OR 3.53, 95% CI [2.42, 5.14]) and third-shock AMSA₃ (OR 3.10, 95% CI [2.03, 4.73]). The median change in AMSA was 0.24 for ΔAMSA₁₋₂ and 0.21 for ΔAMSA₂₋₃. A positive median change in AMSA between shocks was associated with favorable neurologic survival (OR 1.44, 95% CI [1.16, 1.80] for ΔAMSA₁₋₂ and OR 1.31, 95% CI [1.01, 1.71] for ΔAMSA₂₋₃). CONCLUSION: Given their prognostic and dynamic qualities, quantitative waveform measures may provide an effective real-time strategy to guide individual treatment and improve survival.
BACKGROUND: Quantitative measures of the ventricular fibrillation waveform at the outset of resuscitation are associated with survival. However, little is known about the course of these measures during resuscitation and how this course is related to outcome. OBJECTIVE: The purpose of this study was to determine how waveform measures change over the course of resuscitation and whether these changes might be used to guide resuscitation. METHODS: We evaluated 390 persons treated by emergency providers following out-of-hospital ventricular fibrillation arrest. We assessed the ventricular fibrillation waveform using the amplitude spectrum area (AMSA) from the defibrillator's continuous electrocardiogram measured before each of the first three shocks. We used logistic regression to evaluate the relationship of AMSA and the change in AMSA with favorable neurologic survival as determined by the Cerebral Performance Category at hospital discharge 1-2. RESULTS: Of the 390 patients who received an initial shock, 273 required a second shock and 210 required a third shock. The mean (standard deviation) for AMSA was 9.64 (0.52) for the 873 total shock cycles. AMSA₁ measured before the first shock was strongly associated with favorable neurologic survival (odds ratio [OR] 3.40, 95% confidence interval [CI] [2.48, 4.66] for 1 SD change). We observed a similar relationship for second-shock AMSA₂ (OR 3.53, 95% CI [2.42, 5.14]) and third-shock AMSA₃ (OR 3.10, 95% CI [2.03, 4.73]). The median change in AMSA was 0.24 for ΔAMSA₁₋₂ and 0.21 for ΔAMSA₂₋₃. A positive median change in AMSA between shocks was associated with favorable neurologic survival (OR 1.44, 95% CI [1.16, 1.80] for ΔAMSA₁₋₂ and OR 1.31, 95% CI [1.01, 1.71] for ΔAMSA₂₋₃). CONCLUSION: Given their prognostic and dynamic qualities, quantitative waveform measures may provide an effective real-time strategy to guide individual treatment and improve survival.
Authors: Jason Coult; Jennifer Blackwood; Lawrence Sherman; Thomas D Rea; Peter J Kudenchuk; Heemun Kwok Journal: Circ Arrhythm Electrophysiol Date: 2019-01
Authors: David Filgueiras-Rama; Conrado J Calvo; Óscar Salvador-Montañés; Rosalía Cádenas; Jose Ruiz-Cantador; Eduardo Armada; Juan Ramón Rey; J L Merino; Rafael Peinado; Nicasio Pérez-Castellano; Julián Pérez-Villacastín; Jorge G Quintanilla; Santiago Jiménez; Francisco Castells; Francisco J Chorro; J L López-Sendón; Omer Berenfeld; José Jalife; Esteban López de Sá; José Millet Journal: Int J Cardiol Date: 2015-03-14 Impact factor: 4.164
Authors: Michiel Hulleman; David D Salcido; James J Menegazzi; Patrick C Souverein; Hanno L Tan; Marieke T Blom; Rudolph W Koster Journal: Resuscitation Date: 2017-08-24 Impact factor: 5.262
Authors: David D Salcido; Robert H Schmicker; Noah Kime; Jason E Buick; Sheldon Cheskes; Brian Grunau; Stephanie Zellner; Dana Zive; Tom P Aufderheide; Allison C Koller; Heather Herren; Jack Nuttall; Matthew L Sundermann; James J Menegazzi Journal: Resuscitation Date: 2018-05-24 Impact factor: 5.262
Authors: Jason Coult; Heemun Kwok; Lawrence Sherman; Jennifer Blackwood; Peter J Kudenchuk; Thomas D Rea Journal: J Electrocardiol Date: 2017-08-01 Impact factor: 1.438
Authors: Jos Thannhauser; Joris Nas; Priya Vart; Joep L R M Smeets; Menko-Jan de Boer; Niels van Royen; Judith L Bonnes; Marc A Brouwer Journal: Resusc Plus Date: 2021-04-02
Authors: Jos Thannhauser; Joris Nas; Dennis J Rebergen; Sjoerd W Westra; Joep L R M Smeets; Niels Van Royen; Judith L Bonnes; Marc A Brouwer Journal: J Am Heart Assoc Date: 2020-10-02 Impact factor: 5.501
Authors: Pierre S Sebastian; Marinos N Kosmopoulos; Manan Gandhi; Alex Oshin; Matthew D Olson; Adrian Ripeckyj; Logan Bahmer; Jason A Bartos; Evangelos A Theodorou; Demetris Yannopoulos Journal: Resusc Plus Date: 2020-08-12